Whitsett has also added a second new lens for use in cataract procedures — the RxSight Light Adjustable Lens.
The ClearView 3 lens showed success for improving patient vision in clinical trials. The team at Whitsett first performed surgery using the lens last month.
“The ClearView 3 from Lenstec has been designed with increased precision, accuracy and stability, which results in excellent long-term visual outcomes at near, intermediate and distance,” Jeffery Whitsett, MD, founder of the Whitsett Vision Group, said in a Sept. 26 press release.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
